SCHEMBL29968303

SCHEMBL29968303

CC(C)C[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 20/20 0.59
▸ CTSD P07339 5/20 0.59
▸ BACE2 Q9Y5Z0 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29630604 0.92 BACE1 (0.55) BACE1CTSDBACE2
SCHEMBL4064195 0.91 BACE1 (0.66) BACE1CTSDBACE2
SCHEMBL4064179 0.91 BACE1 (0.66) BACE1CTSDBACE2
SCHEMBL31571446 0.90 BACE1 (0.58) BACE1CTSDBACE2
SCHEMBL38665586 0.90 BACE1 (0.63) BACE1CTSDBACE2
SCHEMBL30847600 0.89 BACE1 (0.52) BACE1CTSDBACE2
SCHEMBL30601804 0.89 ENPEP (0.57) BACE1CTSDBACE2
SCHEMBL31753747 0.88 BACE1 (0.53) BACE1CTSDBACE2
SCHEMBL29679529 0.88 BACE1 (0.53) BACE1CTSDBACE2
SCHEMBL29901173 0.87 BACE1 (0.54) BACE1CTSDBACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4304717-A1 USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY Chronic Airway Therapeutics Limited (AU) 2024-01-17 — — EP disclosed
WO-2022192252-A1 USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY CHRONIC AIRWAY THERAPEUTICS LIMITED (AU) 2022-09-15 — — WO disclosed
Send feedback